Inventor
Artiom CERNIJENKO
Inventor
US
Overview
Patents· 9 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes33%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
C07DHeterocyclic compounds33%
PatentTitleYear
12,570,6253-(5-hydroxy-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof202612,479,817Substituted 3-(1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof202512,172,984Pyrazolopyridine derivatives and uses thereof202412,103,9193-(5-oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof202411,833,1423-(5-amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof202311,787,785Pyrazolopyridine derivatives and uses thereof202311,566,0223-(5-methoxy-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof202311,192,8773-(5-hydroxy-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof202111,185,5373-(5-amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2026Patents assigned to NOVARTIS AG (9)· patent assignee history
2021–2026Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| NOVARTIS AG | 9 | 2021–2026 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 9 | 2021–2026 |